EdgarLookup
3/A

PRIMARY DOCUMENT

Company
Monopar Therapeutics
Filed
June 2, 2021
Period of Report
June 1, 2021
Accession Number
0001654954-21-006529
View Document ↗ View on SEC.gov ↗